Carregant...

A major determinant of the immunogenicity of factor VIII in a murine model is independent of its procoagulant function

A main complication of treatment of patients with hemophilia A is the development of anti–factor VIII (fVIII) antibodies. The immunogenicity of fVIII potentially is a function of its procoagulant activity, which may result in danger signals that drive the immune response. Alternatively, intrinsic st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Meeks, Shannon L., Cox, Courtney L., Healey, John F., Parker, Ernest T., Doshi, Bhavya S., Gangadharan, Bagirath, Barrow, Rachel T., Lollar, Pete
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3448263/
https://ncbi.nlm.nih.gov/pubmed/22855607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-412361
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!